Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Treated Patients 13 to 30

<< Previous

Bullboard Posts

Next >>

Comment by 99942Apophison Mar 10, 2022 3:24pm

259 Views

Post# 34504118

RE:RE:RE:RE:Treated Patients 13 to 30

Hi DJDawg yes my calculations were done from scratch, I make my calculations from announced news releases or newsletters. I can only guess that the PR & NR came mostly out of the first group of 12 so that is why my post were only on the optimized patients 13 to 30 of PH2. I don't take anything for granted in my numbers. Whenever new patients are announced I add them to my paper chart only because I can see it for future reference. Does that make me anal?
Anyone finding an error in my calculations please point it out to me, as they say you can make the same mistake more then once lol, have a good day.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?